Full Press Release Details
Ionis Announces Submission of New Drug Application (NDA) for Inotersen to the U.S. FDA.
IONS
Ionis Announces Submission of New Drug Application (NDA) for Inotersen to the U.S. FDA
Key Takeaway: Ionis Announces Submission of New Drug Application (NDA) for Inotersen to the U.S. FDA